Palla Pharma Ltd (pal) Logo

Palla Pharma Ltd (PAL)

___:___ · AUD
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

PAL Chart

PAL's Principal Activity is the production and distribution of Narcotic Raw Material ("NRM"), Active Pharmaceutical Ingredients ("API") and Finished Dosage Formulations ("FDF") for supply to international pharmaceutical markets, and the production and distribution of poppy seed for supply to international culinary markets.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2021 YTD
1 Year
vs Sector (1yr) -10.64%
vs ASX 200 (1yr) -48.03%

Size

Market Capitalisation
ASX Rank 1142 of 2,564
Sector Rank 97 of 177

Key Information

Shares Issued
Sector Healthcare
Similar Companies IDT / ZLD / OSL
EPS -$0.276
DPS $0.00
NTA per share $0.25

Broker Consensus

PAL is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Company Overview

Palla Pharma Limited (PAL, formerly TPI Enterprises Limited) is a vertically integrated opiate manufacturer from poppy straw growing through to tableting production. PAL has developed an efficient and environmentally sustainable opiate manufacturing process based on a novel water-based extraction technology. Palla Pharma is a global business with Australian operations in Victoria and Tasmania; and northern hemisphere operations based in Norway.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Melbourne VIC 3000
Website www.pallapharma.com
Registry Link Market Services
Auditor KPMG
Date Listed 13 Aug 2015

Upcoming Calendar

Date Event
30/08/2021 Report (Interim)
25/02/2022 Report (Prelim)
18/03/2022 Report (Annual)

Dividend History

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Mr Iain Ross Non-Executive Director Dec 2020 Director Bio icon

Mr Iain Ross

Non-Executive Director

Mr Ross has over 40 years experience in the international pharmaceutical and biotechnology sectors, where he has held leadership positions as an executive and board Member in range of companies. Currently, he is Chairman of Silence Therapeutics plc, Redx Pharma plc. Previously he has held senior executive positions at range of companies including Sandoz AG, Fisons plc, Hoffmann La Roche AG and Celltech Group plc.

Mr Brendan Middleton Chief Financial Officer,Interim Chief Executive Officer Dec 2020
Mr Mark Andrew Licciardo Company Secretary May 2020
Ms Sue MacLeman Non-Executive Director Nov 2018 Director Bio icon

Ms Sue MacLeman

Non-Executive Director

Ms MacLeman has more than 30 years experience as a pharmaceutical, biotechnology and medical technology executive having held senior roles in corporate, medical, commercial and business development. She has also served as CEO and Board member of several listed companies in the pharmaceutical sector and is currently Chair of Oventus Medical Ltd , Chair of Anatara Lifesciences Ltd, Chair of Tali Digital Ltd, Chair of MTPConnect (MTPII-GC Ltd) and Non-Executive Director of Planet Innovation Holdings Ltd. She was a Non-Executive Director of RHS Limited (2014 to 2018). She is Chair of the Human Capital Committee and a member of the Risk Committee.

Mr Stuart Alexander Black Non-Executive Director Jun 2016 Director Bio icon

Mr Stuart Alexander Black

Non-Executive Director

Mr Black has experience in agribusiness. He retired in 2013 as managing partner of a practice specialising in agribusiness. He was a Past President of the Institute of Chartered Accountants of Australia. He was the inaugural Chair and a past board Member of the Accounting Professional and Ethical Standards Board and served as the Australian representative on the International Federation of Accountants SMP Committee. He is Chair of the Chartered Accountants Benevolent Fund Limited and a former Director of the Country Education Foundation of Australia Limited. He was a former Non-Executive Director of NetComm Wireless Limited (2013 to 2019). He is Chair of the Risk Committee and a member of the Human Capital Committee.

Mr Simon Colinton Moore Non-Executive Director,Non-Executive Chairman Jun 2016 Director Bio icon

Mr Simon Colinton Moore

Non-Executive Director,Non-Executive Chairman

Mr Moore is currently a Non-Executive Director of Alexium International Group Limited. He is a Senior Partner of Colinton Capital Partners. He was formerly a Managing Director and Partner of global alternative asset manager, The Carlyle Group. Prior, he was a Managing Director and Investment Committee Member of Investcorp International, Inc. Prior to that he worked in private equity investments and investment banking at J.P. Morgan & Co. in New York, Hong Kong and Melbourne. His personal investments include pastoral holdings and investments in a number of agricultural enterprises. He is a Non-Executive Director of Megaport Limited (2015 to 2019), Non-Executive Director of First Wave Cloud Technology Limited (2017 to 2019). He is a member of the Human Capital Committee.

Director Transactions

PAL directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
12/04/21 Iain Ross Buy +75,000 $0.476 $35,700 On-market trade
29/03/21 Stuart Black Issued 26,228 $0.50 $13,114 Rights issue
08/03/21 Simon Moore Buy +658,644 $0.50 $329,322 Placement
08/03/21 Simon Moore Buy +13,791 $0.50 $6,895 Placement
18/11/19 Jarrod Ritchie Issued 209,025 $0.70 $146,318 Rights issue
18/11/19 Simon Moore Issued 871,884 $0.70 $610,319 Rights issue
18/11/19 Stuart Black Issued 8,772 $0.70 $6,140 Rights issue
18/11/19 Jarrod Ritchie Issued 394,956 $0.70 $276,469 Rights issue

Director Interests

The current holdings of PAL directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Iain Ross 12/04/2021 75,000 N/A N/A N/A
Stuart Black 29/03/2021 N/A 50,000 N/A N/A
Simon Moore 08/03/2021 13,791 3,684,595 N/A N/A
Sue MacLeman 27/11/2018 0 N/A N/A N/A

Shareholder Info

Top 20 Shareholders About the Data

Data supplied by Morningstar and accurate on Mar 2, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Washington H. Soul Pattinson and Company Limited 25,040,465 19.90%
UBS Nominees Pty Ltd 23,807,796 18.90%
National Nominees Limited 11,587,496 9.20%
Sandhurst Trustees Ltd 10,219,291 8.10%
Skylights Pty Ltd 5,079,738 4.00%
BNP Paribas Nominees Pty Ltd SIX SIS Ltd 3,950,546 3.10%
Colinton Investments Pty Ltd 2,963,895 2.40%
Sico Holdings Pty Ltd 2,740,741 2.20%
Bond Street Custodians Limited 1,792,913 1.40%
Gaspard Boot 1,498,000 1.20%
Jarrod Ritchie & Catrina Ritchie 1,381,177 1.10%
Gowing Bros Limited 1,064,914 0.80%
HSBC Custody Nominees (Australia) Limited 1,032,464 0.80%
JP Morgan Nominees Australia Pty Limited 801,521 0.60%
Mr Jarrod David Ritchie 731,587 0.60%
Langburgh Pty Ltd 723,173 0.60%
Radiata Super Pty Ltd 701,060 0.60%
Cowoso Capital Pty Ltd 675,000 0.50%
Beebee Holdings Pty Ltd 556,715 0.40%
Australian Philanthropic Services Foundation Pty Ltd 500,000 0.40%
Mr Joris Arjen Lugtenburg & Mrs Adriane Lugtenburg 500,000 0.40%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 366 579 257 468 88 1,758

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Sico Holdings Pty Ltd 02/03/2021 8,361,889 6.60
National Nominees Ltd 02/03/2021 7,987,076 6.30
Washington H. Soul Pattinson and Company Limited 02/03/2021 25,040,465 19.90
Thorney Opportunities Ltd 02/03/2021 23,807,796 18.90
Wentworth Williamson Management Pty Ltd 02/03/2021 11,587,496 9.20

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2020 $0.80 30 June
2019 $1.06 28 June
Page Icon
PAL Historical Price Data (CSV)
Up to 20 years of EOD share price history
Lock Icon
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.